Martiniclinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
On average, patients remain hospitalized no more than 2 days after MIRP. The aim of our study was to examine the temporal trends in length of stay ≥3 days and to test the relationship between annual surgical volume (ASV) and annual hospital volume (AHV) and length of stay ≥3 days in patients undergoing MIRP.
Within the Florida Hospital Inpatient Datafile, 2439 men who were treated with MIRP for prostate cancer between 2005 and 2008 were identified. Temporal trends were assessed and uni and multi-variable logistic regression models tested the relationship between ASV, AHV and length of stay ≥3 days.
The average length of stay decreased from 2.4 in 2005 to 1.7 days in 2008. Length of stay ≥3 days was recorded in 13.6% of patients and the proportion of patients staying more than ≥3 days decreased over time (25.5-12.2%; Chi Square trend p < 0.001). After stratification into low (< 1-15 MIRPs) vs. intermediate (16-63 MIRPs) vs. high ASV tertiles (≥64 MIRPs) the proportion of patients with length of stay ≥3 days were 29.1; 13.2 and 11.1%. In multivariable logistic regression models predicting length of stay ≥3 days, ASV, year of surgery and comorbidities achieved independent predictor status and MIRP patients operated by highest ASV tertile surgeons were 71% (p < 0.001) less likely to be hospitalized for more than 3 days.
The length of stay after MIRP decreased between 2005 and 2008. Surgical expertise represented one of the main determinants of shorter length of stay.
Written by:
Budäus L, Morgan M, Abdollah F, Zorn KC, Sun M, Johal R, Thuret R, Abdo A, Schmitges J, Isbarn H, Jeldres C, Perrotte P, Graefen M, Karakiewicz PI. Are you the author?
Reference: Eur J Surg Oncol. 2011 May;37(5):429-34.
PubMed Abstract
PMID: 21492776
UroToday.com Prostate Cancer Section
